After MEK inhibition, MEKi-resistant CRC cells showed an initial reduction in the level of phosphorylated ERK, which was restored within 72 h, accompanied by an increased RAS-GTP level (Fig. 7C, D). This evidence concerns the gene MAP2K7 and colorectal carcinoma.